Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.
作者信息
Terzic Andre, Alekseev Alexey E, Yamada Satsuki, Reyes Santiago, Olson Timothy M
机构信息
Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Internal Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Department of Medical Genetics, Mayo Clinic, Rochester, MN, USA.
出版信息
Circ Arrhythm Electrophysiol. 2011 Aug;4(4):577-85. doi: 10.1161/CIRCEP.110.957662.
Abstract
摘要
相似文献
1
Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.心脏ATP敏感性钾通道病从分子到群体的研究进展
Circ Arrhythm Electrophysiol. 2011 Aug;4(4):577-85. doi: 10.1161/CIRCEP.110.957662.
2
Channelopathies: decoding disease pathogenesis.通道病：解码疾病发病机制。
Sci Transl Med. 2010 Jul 28;2(42):42ps37. doi: 10.1126/scitranslmed.3001433.
3
Human K(ATP) channelopathies: diseases of metabolic homeostasis.人类 K(ATP)通道病：代谢稳态的疾病。
Pflugers Arch. 2010 Jul;460(2):295-306. doi: 10.1007/s00424-009-0771-y. Epub 2009 Dec 24.
4
Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure.血管紧张素II和肿瘤坏死因子α作为心肌梗死后心力衰竭中ATP依赖性钾通道重塑的介质
Cardiovasc Res. 2009 Sep 1;83(4):726-36. doi: 10.1093/cvr/cvp162. Epub 2009 May 21.
5
Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy.机械不同步先于 ATP 敏感性钾通道缺陷性扩张型心肌病的 QRS 波增宽。
J Am Heart Assoc. 2013 Dec 5;2(6):e000410. doi: 10.1161/JAHA.113.000410.
6
The genetics of cardiac arrhythmias.心律失常的遗传学
Pacing Clin Electrophysiol. 2000 Jan;23(1):106-19. doi: 10.1111/j.1540-8159.2000.tb00655.x.
7
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.普伐他汀对心肌梗死后大鼠交感神经再支配的影响。
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3617-26. doi: 10.1152/ajpheart.00875.2007. Epub 2007 Sep 21.
8
Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning.线粒体ATP敏感性钾通道的内源性激活可保护人类衰竭心肌免受羟自由基诱导的顿抑。
Circ Res. 2009 Oct 9;105(8):811-7. doi: 10.1161/CIRCRESAHA.109.206359. Epub 2009 Sep 3.
9
Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.在4日龄慢性梗死麻醉猪模型中，给予KATP通道开放剂苄甲卡利后，室性心动过速周期长度呈剂量相关缩短。
J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):222-30. doi: 10.1177/1074248409338929. Epub 2009 Jul 8.
10
Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.心脏衰竭中心外基质重构的多尺度分析。
Circ Res. 2021 Jan 8;128(1):24-38. doi: 10.1161/CIRCRESAHA.120.317685. Epub 2020 Oct 27.
引用本文的文献
1
Mitochondrial dysfunction is a key link involved in the pathogenesis of sick sinus syndrome: a review.线粒体功能障碍是病态窦房结综合征发病机制中的关键环节：综述
Front Cardiovasc Med. 2024 Oct 29;11:1488207. doi: 10.3389/fcvm.2024.1488207. eCollection 2024.
2
Evaluation of Atrial Electromechanical Delay and Left Atrial Phasic Function in Individuals with Electrocardiographic Early Repolarization Pattern.心电图早期复极模式个体的心房电机械延迟和左心房阶段性功能评估
Acta Cardiol Sin. 2022 Nov;38(6):714-722. doi: 10.6515/ACS.202211_38(6).20220813A.
3
K channel dependent heart multiome atlas.K 通道依赖型心脏多组学图谱。
Sci Rep. 2022 May 5;12(1):7314. doi: 10.1038/s41598-022-11323-4.
4
Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy.再生疗法可预防不同步性非缺血性窄QRS波心肌病的心力衰竭进展。
J Am Heart Assoc. 2015 May 11;4(5):e001614. doi: 10.1161/JAHA.114.001614.
5
Antiobesity strategy targets energy economy safeguards.抗肥胖策略以能量节约保障措施为目标。
Mol Ther. 2015 Apr;23(4):615-6. doi: 10.1038/mt.2015.39.
6
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.ABCC9 是一个新的 Brugada 和早期复极综合征易感性基因。
Int J Cardiol. 2014 Feb 15;171(3):431-42. doi: 10.1016/j.ijcard.2013.12.084. Epub 2014 Jan 4.
7
Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy.机械不同步先于 ATP 敏感性钾通道缺陷性扩张型心肌病的 QRS 波增宽。
J Am Heart Assoc. 2013 Dec 5;2(6):e000410. doi: 10.1161/JAHA.113.000410.
本文引用的文献
1
Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.2020年临床转化科学：颠覆性创新重新定义了发现应用型企业。
Clin Transl Sci. 2011 Feb;4(1):69-71. doi: 10.1111/j.1752-8062.2011.00261.x.
2
K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.K(ATP) 通道依赖的代谢组学解码：心力衰竭预测、诊断和治疗的系统方法。
Cardiovasc Res. 2011 May 1;90(2):258-66. doi: 10.1093/cvr/cvr046. Epub 2011 Feb 14.
3
Translational medicine: path to personalized and public health.转化医学：通往个性化医疗与公共卫生之路。
Biomark Med. 2010 Dec;4(6):787-90. doi: 10.2217/bmm.10.101.
4
Clinical and translational science: from bench-bedside to global village.临床与转化科学：从实验室到床边再到地球村。
Clin Transl Sci. 2010 Oct;3(5):254-7. doi: 10.1111/j.1752-8062.2010.00227.x.
5
K(ATP) channels process nucleotide signals in muscle thermogenic response.K(ATP) 通道在肌肉产热反应中处理核苷酸信号。
Crit Rev Biochem Mol Biol. 2010 Dec;45(6):506-19. doi: 10.3109/10409238.2010.513374. Epub 2010 Oct 7.
6
Channelopathies: decoding disease pathogenesis.通道病：解码疾病发病机制。
Sci Transl Med. 2010 Jul 28;2(42):42ps37. doi: 10.1126/scitranslmed.3001433.
7
Muscle KATP channels: recent insights to energy sensing and myoprotection.肌 KATP 通道：能量感应和肌保护的新见解。
Physiol Rev. 2010 Jul;90(3):799-829. doi: 10.1152/physrev.00027.2009.
8
Cardiomyocyte sulfonylurea receptor 2-KATP channel mediates cardioprotection and ST segment elevation.心肌细胞磺酰脲受体 2-KATP 通道介导心脏保护和 ST 段抬高。
Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1100-8. doi: 10.1152/ajpheart.00084.2010. Epub 2010 Jul 23.
9
Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.KCNJ8 编码的心脏 K(ATP) 通道 Kir6.1 中的功能获得性突变 S422L 作为 J 波综合征的致病底物。
Heart Rhythm. 2010 Oct;7(10):1466-71. doi: 10.1016/j.hrthm.2010.06.016. Epub 2010 Jun 15.
10
Network systems biology for drug discovery.网络系统生物学在药物发现中的应用。
Clin Pharmacol Ther. 2010 Jul;88(1):120-5. doi: 10.1038/clpt.2010.91. Epub 2010 Jun 2.
Zotero 插件